Deferiprone Not Beneficial for Newly Diagnosed Parkinson Disease
THURSDAY, Dec. 1, 2022 (HealthDay News) — For patients newly diagnosed with Parkinson disease, deferiprone is associated with worse scores in measures of parkinsonism, according to a study published in the Dec. 1 issue of the New England Journal of M…
Learn MoreBuprenorphine Use in Pregnancy May Reduce Risk for Adverse Neonatal Outcomes
THURSDAY, Dec. 1, 2022 (HealthDay News) — The risk for adverse neonatal outcomes is lower with use of buprenorphine versus methadone in pregnancy, according to a study published in the Dec. 1 issue of the New England Journal of Medicine.Elizabeth A. …
Learn MoreLecanemab Reduced Markers of Amyloid in Early Alzheimer Disease
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — For patients with early Alzheimer disease, lecanemab reduced markers of amyloid and resulted in moderately less decline in cognition and function at 18 months, according to a study published online Nov. 29 …
Learn MoreUse of New-to-Market Neurologic Medications Reported to Be Low
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — Utilization of new-to-market neurologic medications in the privately insured population remains low, according to a study published online Nov. 30 in Neurology.Evan L. Reynolds, Ph.D., from the University o…
Learn MoreConvection-Enhanced Delivery of Topotecan Active in Glioblastoma
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — A subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastoma, according to a stud…
Learn MoreBenzodiazepine Exposure in Pregnancy Does Not Up Risk for ADHD, Autism
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — Benzodiazepine exposure during pregnancy seems not to be associated with increased risks for development of attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD), according to a …
Learn MoreExtended-Release Morphine Does Not Reduce Breathlessness in COPD
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — Daily low-dose extended release morphine does not significantly reduce the intensity of worst breathlessness among people with chronic obstructive pulmonary disease (COPD) and severe chronic breathlessness,…
Learn MoreSecond Death in Trial of Experimental Alzheimer Drug Raising Concerns
TUESDAY, Nov. 29, 2022 (HealthDay News) — Two people have now died from brain hemorrhages that may be linked to an experimental drug for Alzheimer disease, calling into question the medication’s safety.A 65-year-old woman with early-stage Alzheimer d…
Learn MoreRisk of Uterine Diseases, Cancers Up With Tamoxifen Treatment
TUESDAY, Nov. 29, 2022 (HealthDay News) — Tamoxifen treatment is associated with increased risk of endometrial hyperplasia, polyps, and carcinoma, as well as other uterine cancers, according to a study published online Nov. 28 in JAMA Network Open.Ki…
Learn MoreCombination Treatment Beneficial in Albuminuric CKD
TUESDAY, Nov. 29, 2022 (HealthDay News) — For patients with albuminuric chronic kidney disease (CKD) without diabetes, treatment with the combination of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and sodium-glucose cotrans…
Learn More